{
    "clinical_study": {
        "@rank": "26", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining chemotherapy with radiation therapy may kill more\n      tumor cells. Bone marrow transplantation can replace immune cells that were destroyed by\n      chemotherapy.\n\n      PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy compared with\n      or without bone marrow transplantation in treating patients with acute lymphoblastic\n      leukemia."
        }, 
        "brief_title": "Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia", 
        "condition": [
            "Leukemia", 
            "Lymphoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
                "Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare the remission induction, toxicity, and duration of remission in patients with\n           newly diagnosed acute lymphoblastic leukemia or lymphoblastic lymphoma treated with\n           prednisone vs dexamethasone plus cyclophosphamide, daunorubicin, and vincristine as\n           induction.\n\n        -  Compare the survival and disease-free survival of patients treated with autologous bone\n           marrow transplantation (BMT) followed by low- or high-intensity maintenance\n           chemotherapy with cranial irradiation after consolidation.\n\n        -  Determine the relative and disease-free survival of patients treated with autologous or\n           allogeneic BMT after identical induction, consolidation, and conditioning regimens.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to\n      center and risk group (high vs standard).\n\n      Induction\n\n        -  Patients are randomized to 1 of 2 treatment arms.\n\n             -  Arm I:Patients receive daunorubicin IV on days 1-3 and 15 and 16; cyclophosphamide\n                (CTX) IV on days 1 and 8; vincristine (VCR) IV on days 1, 8, 15, and 22; and\n                prednisone IV or orally every 8 hours on days 1-7 and 15-21.\n\n             -  Arm II: Patients receive daunorubicin, CTX, and VCR as in arm I and dexamethasone\n                IV or orally on days 1-8 and 15-22.\n\n        -  Patients on both arms without CNS disease at presentation receive CNS prophylaxis\n           comprising methotrexate (MTX) intrathecally (IT) on days 1, 8, 15, and 22. Patients on\n           both arms with CNS disease at presentation receive CNS therapy comprising\n           hydrocortisone (HC) IT and MTX IT alternating with cytarabine (ARA-C) IT twice a week\n           until CSF clears. After induction, patients on both arms proceed to consolidation,\n           regardless of response.\n\n      Consolidation\n\n        -  Patients receive ARA-C IV over 2 hours every 12 hours on days 29-34 and mitoxantrone IV\n           on days 33-35. Patients without CNS disease at presentation receive CNS prophylaxis\n           comprising MTX IT on day 29. Patients with CNS disease at presentation receive CNS\n           therapy comprising HC IT and MTX IT alternating with ARA-C weekly for 6 weeks. Patients\n           who achieve complete response (CR) at day 55-60 receive MTX IV on days 64 and 79,\n           leucovorin calcium IV or orally every 6 hours on days 65-67 and 80-82, and asparaginase\n           IV over 1 hour or intramuscularly on days 65 and 80.\n\n        -  Standard-risk patients who are under age 20 and achieve CR after day 80 are assigned to\n           arm IV of group A. Patients who achieve CR after day 80 and have a genotypically or\n           phenotypically HLA-matched family donor, a family donor mismatched at only 1 locus (A,\n           B, or DR), or an HLA-matched unrelated donor proceed to group B. Patients who achieve\n           CR after day 80 and are eligible for autologous bone marrow transplantation (BMT)\n           proceed to group A. Patients found to be at extremely high risk are taken off study.\n\n      Group A\n\n        -  Patients are randomized to 1 of 2 treatment arms.\n\n             -  Arm III: Autologous bone marrow is harvested. Patients receive bone marrow\n                ablation comprising CTX IV over 1 hour on days -4 and -3 and total body\n                irradiation on day -1. Autologous bone marrow is reinfused on day 0. Beginning at\n                month 8 (4 months after BMT), patients receive first maintenance comprising VCR\n                IV, doxorubicin IV, and dexamethasone IV (VAD) or VCR IV, doxorubicin IV, and\n                prednisolone IV (VAP) on days 1-4 and 29-32. Patients receive second maintenance\n                comprising oral mercaptopurine daily and oral MTX daily beginning at month 10 and\n                continuing through year 3. Patients without CNS disease at presentation receive\n                CNS prophylaxis comprising MTX IT on days 1 and 29. Patients with CNS disease at\n                presentation receive CNS therapy comprising ARA-C IT, MTX IT, and HC IT beginning\n                at 1 month after BMT and continuing monthly for 1 year and then every 3 months\n                through year 3.\n\n             -  Arm IV: Patients receive CTX IV and ARA-C IV continuously on day 1, oral\n                mercaptopurine on days 8-28, and oral MTX on days 8, 15, and 22 during months 4,\n                7, 11, 13, 17, 21, 25, and 29. Patients receive MTX IV over 30 minutes on day 1,\n                leucovorin calcium IV or orally every 6 hours on days 2-4, asparaginase IV over 1\n                hour or intramuscularly on day 2, oral mercaptopurine on days 8-28, and oral MTX\n                on days 8, 15, and 22 during months 6, 10, 12, 15, 19, 23, and 27. Patients\n                receive VAD or VAP as in arm III beginning at month 8. Patients without CNS\n                disease at presentation receive CNS prophylaxis comprising whole brain\n                radiotherapy and MTX IT on day 1 of radiotherapy during month 5. Patients with CNS\n                disease at presentation receive CNS therapy as in arm III.\n\n      Group B\n\n        -  Allogeneic bone marrow is harvested. Patients receive bone marrow ablation as in arm\n           III beginning on day 100. Allogeneic bone marrow is infused over 15-30 minutes on day\n           0.\n\n             -  Patients in groups A and B with CNS disease at presentation undergo radiotherapy\n                to focal infiltration at entry or concurrently with total body irradiation, or\n                whole brain radiotherapy during maintenance (if no prior CNS irradiation). At any\n                time during the study, patients who develop marrow relapse (more than 5% leukemic\n                blasts in bone marrow on 2 occasions), CNS relapse (blasts in CSF, cranial nerve\n                palsy, or CNS mass), or testis or other extramedullary relapse are taken off\n                study.\n\n      PROJECTED ACCRUAL: A total of 392 patients will be accrued for this study within\n      approximately 6 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Newly diagnosed acute lymphoblastic leukemia or lymphoblastic lymphoma with more than\n             30% blasts in bone marrow\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  15 to 60\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  See Disease Characteristics\n\n        Hepatic:\n\n          -  Bilirubin less than 2 mg/dL (unless elevation due to leukemic involvement of liver)\n\n        Renal:\n\n          -  Creatinine less than 2 mg/dL (unless elevation due to leukemic involvement of\n             kidneys)\n\n        Cardiovascular:\n\n          -  No severe cardiac disease\n\n        Pulmonary:\n\n          -  No severe pulmonary disease\n\n        Other:\n\n          -  No severe neurologic or metabolic disease\n\n          -  HIV negative (if tested)\n\n          -  No other prior malignancy except nonmelanomatous skin cancer, stage I cervical\n             carcinoma, or other curatively treated malignancy\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No prior biologic therapy\n\n        Chemotherapy:\n\n          -  No prior chemotherapy\n\n        Endocrine therapy:\n\n          -  No prior endocrine therapy\n\n        Radiotherapy:\n\n          -  No prior radiotherapy\n\n        Surgery:\n\n          -  No prior surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "392", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002700", 
            "org_study_id": "EORTC-06951", 
            "secondary_id": [
                "EORTC-06951", 
                "FRE-LALA-94"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "asparaginase", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cytarabine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "daunorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "dexamethasone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "leucovorin calcium", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "mercaptopurine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "methotrexate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "mitoxantrone hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "prednisolone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "prednisone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "therapeutic hydrocortisone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "vincristine sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "allogeneic bone marrow transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "autologous bone marrow transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "6-Mercaptopurine", 
                "Cytarabine", 
                "Methotrexate", 
                "Cyclophosphamide", 
                "Asparaginase", 
                "Daunorubicin", 
                "Dexamethasone", 
                "Doxorubicin", 
                "Prednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Mitoxantrone", 
                "Prednisone", 
                "Vincristine", 
                "BB 1101", 
                "Dexamethasone acetate", 
                "Cortisol succinate", 
                "Hydrocortisone acetate", 
                "Hydrocortisone 17-butyrate 21-propionate", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Hydrocortisone", 
                "Methylprednisolone", 
                "Dexamethasone 21-phosphate", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate", 
                "Hydrocortisone-17-butyrate", 
                "Leucovorin", 
                "Levoleucovorin"
            ]
        }, 
        "keyword": [
            "untreated adult acute lymphoblastic leukemia", 
            "stage I adult lymphoblastic lymphoma", 
            "stage III adult lymphoblastic lymphoma", 
            "stage IV adult lymphoblastic lymphoma", 
            "contiguous stage II adult lymphoblastic lymphoma", 
            "noncontiguous stage II adult lymphoblastic lymphoma"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-06951"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium", 
                        "zip": "B-2020"
                    }, 
                    "name": "Algemeen Ziekenhuis Middelheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brugge", 
                        "country": "Belgium", 
                        "zip": "8000"
                    }, 
                    "name": "A.Z. St. Jan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "C.H.U. Saint-Pierre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege", 
                        "country": "Belgium", 
                        "zip": "B-4000"
                    }, 
                    "name": "CHU Sart-Tilman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Verviers", 
                        "country": "Belgium", 
                        "zip": "B-4800"
                    }, 
                    "name": "Centre Hospitalier Peltzer-La Tourelle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zagreb", 
                        "country": "Croatia", 
                        "zip": "10000"
                    }, 
                    "name": "University Hospital Rebro"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zagreb (Agram)", 
                        "country": "Croatia", 
                        "zip": "10000"
                    }, 
                    "name": "Medical School/University of Zagreb"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olomouc", 
                        "country": "Czech Republic", 
                        "zip": "775 20"
                    }, 
                    "name": "University Hospital - Olomouc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437"
                    }, 
                    "name": "Hopital Edouard Herriot"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75743"
                    }, 
                    "name": "Hopital Necker"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75181"
                    }, 
                    "name": "Hotel Dieu de Paris"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suresnes", 
                        "country": "France", 
                        "zip": "92151"
                    }, 
                    "name": "Centre Medico-Chirurgical Foch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meissen", 
                        "country": "Germany", 
                        "zip": "D-01662"
                    }, 
                    "name": "Kreiskrankenhaus Meissen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alessandria", 
                        "country": "Italy", 
                        "zip": "I-15100"
                    }, 
                    "name": "Ospedale Civile Alessandria"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Avellino", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale Civile Avellino"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy", 
                        "zip": "70124"
                    }, 
                    "name": "Universita Degli Studi di Bari Policlinico"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brindisi", 
                        "country": "Italy", 
                        "zip": "72100"
                    }, 
                    "name": "A. Perrino Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy", 
                        "zip": "95124"
                    }, 
                    "name": "Ospedale Ferrarotto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Catanzaro", 
                        "country": "Italy", 
                        "zip": "88100"
                    }, 
                    "name": "Ospedale Regionale A. Pugliese"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cuneo", 
                        "country": "Italy", 
                        "zip": "12100"
                    }, 
                    "name": "Ospedale Santa Croce"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze (Florence)", 
                        "country": "Italy", 
                        "zip": "50134"
                    }, 
                    "name": "Policlinico di Careggi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Foggia", 
                        "country": "Italy", 
                        "zip": "71100"
                    }, 
                    "name": "Ospedali Riuniti Foggia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gallarate Varese", 
                        "country": "Italy", 
                        "zip": "21013"
                    }, 
                    "name": "Ospedale S. Antonio Abate"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Latina", 
                        "country": "Italy", 
                        "zip": "04100"
                    }, 
                    "name": "Ospedale Gen. Provinciale Santa Maria Goretti"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodi", 
                        "country": "Italy", 
                        "zip": "I-20075"
                    }, 
                    "name": "Ospedale Maggiore Lodi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montefiascone", 
                        "country": "Italy", 
                        "zip": "I-01027"
                    }, 
                    "name": "Ospedale Di Montefiascone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples (Napoli)", 
                        "country": "Italy", 
                        "zip": "80136"
                    }, 
                    "name": "Ospedale S. Gennaro ASL NA1"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy", 
                        "zip": "90100"
                    }, 
                    "name": "Policlinico - Cattedra di Ematologia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perugia", 
                        "country": "Italy", 
                        "zip": "06122"
                    }, 
                    "name": "Policlinico Monteluce"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Potenza", 
                        "country": "Italy", 
                        "zip": "85100"
                    }, 
                    "name": "Ospedale San Carlo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Giovanni - Rotondo", 
                        "country": "Italy", 
                        "zip": "71013"
                    }, 
                    "name": "Ospedale Casa Sollievo della Sofferenza"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sassari", 
                        "country": "Italy", 
                        "zip": "07100"
                    }, 
                    "name": "Istituto di Ematologia Universita - University di Sassari"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taranto", 
                        "country": "Italy", 
                        "zip": "74100"
                    }, 
                    "name": "Ospedal SS Annunziata"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turin (Torino)", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "Ospedale Molinette"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "'s-Hertogenbosch", 
                        "country": "Netherlands", 
                        "zip": "5211 NL"
                    }, 
                    "name": "Groot Ziekengasthuis 's-Hertogenbosch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1091 HA"
                    }, 
                    "name": "Onze Lieve Vrouwe Gasthuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5631 BM"
                    }, 
                    "name": "Maxima Medisch Centrum - locatie Eindhoven"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2300 CA"
                    }, 
                    "name": "Leiden University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6500 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto", 
                        "country": "Portugal", 
                        "zip": "4200"
                    }, 
                    "name": "Hospital Escolar San Joao"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia", 
                        "zip": "85107"
                    }, 
                    "name": "Institute of Hematology & Transfusiology, University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Ibn-i Sina Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Croatia", 
                "Czech Republic", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Slovakia", 
                "Turkey"
            ]
        }, 
        "official_title": "A RANDOMIZED PHASE III TRIAL COMPARING DEXAMETHASONE WITH PREDNISONE IN INDUCTION TREATMENT AND BONE MARROW TRANSPLANTATION WITH INTENSIVE MAINTENANCE TREATMENT IN ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL-4)", 
        "overall_official": [
            {
                "affiliation": "Leiden University Medical Center", 
                "last_name": "Roel Willemze, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Acute Leukemia French Association", 
                "last_name": "Denis Fiere, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2004", 
            "@type": "Actual"
        }, 
        "reference": [
            {
                "citation": "Reman O, Pigneux A, Huguet F, et al.: Central nervous system involvement in adult acute lymphoblastic leukemia (ALL) at diagnosis and/or at first elapse: results from the GET-LALA group. [Abstract] Blood 110 (11): A-4326, 2007."
            }, 
            {
                "PMID": "17963265", 
                "citation": "Tavernier E, Le QH, de Botton S, Dh\u00e9din N, Bulabois CE, Reman O, Vey N, Lh\u00e9ritier V, Dombret H, Thomas X. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials. Cancer. 2007 Oct 26;110(12):2747-2755 [Epub ahead of print]"
            }, 
            {
                "PMID": "16357838", 
                "citation": "Dh\u00e9din N, Dombret H, Thomas X, Lh\u00e9ritier V, Boiron JM, Rigal-Huguet F, Vey N, Kuentz M, Reman O, Witz F, Delannoy A, Kovacsovics T, Bradstock K, Charrin C, Boucheix C, Gabert J, Blaise D, Fi\u00e8re D, Vernant JP. Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia. 2006 Feb;20(2):336-44."
            }, 
            {
                "PMID": "17039237", 
                "citation": "Picard C, Hayette S, Bilhou-Nabera C, Cayuela JM, Delabesse E, Frenoy N, Preudhomme C, Dupont M, Bastard C, Bories D, Vaerman JL, Davi F, Dastugue N, Raynaud S, Lafage M, Deschaseaux F, Fest T, Gaub MP, Lheritier V, Thomas X, Charrin C, Boucheix C, Dombret H, Macintyre E, Fiere D, Gabert J. Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience. Leukemia. 2006 Dec;20(12):2178-81. Epub 2006 Oct 12. No abstract available."
            }, 
            {
                "PMID": "15039281", 
                "citation": "Charrin C, Thomas X, Ffrench M, Le QH, Andrieux J, Mozziconacci MJ, Lai JL, Bilhou-Nabera C, Michaux L, Bernheim A, Bastard C, Mossafa H, Perot C, Maarek O, Boucheix C, Lheritier V, Delannoy A, Fiere D, Dastugue N. A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL). Blood. 2004 Oct 15;104(8):2444-51. Epub 2004 Mar 23."
            }, 
            {
                "PMID": "12610173", 
                "citation": "Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T, Rousselot P, Cayuela JM, Gabert J, Fegueux N, Piguet C, Huguet-Rigal F, Berthou C, Boiron JM, Pautas C, Michel G, Fiere D, Leverger G, Dombret H, Baruchel A. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003 Mar 1;21(5):774-80. Epub 2003 Mar 1."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002700"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "20378563", 
                "citation": "Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G, Berneman Z, Jaksic B, Feremans W, Bron D, Sinnige H, Mistrik M, Vreugdenhil G, De Bock R, Nemet D, Gilotay C, Amadori S, de Witte T; EORTC Leukemia Group. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica. 2010 Sep;95(9):1489-95. doi: 10.3324/haematol.2009.018580. Epub 2010 Apr 7."
            }, 
            {
                "PMID": "17407135", 
                "citation": "Le QH, Thomas X, Ecochard R, Iwaz J, Lheritier V, Michallet M, Fiere D. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial. Cancer. 2007 May 15;109(10):2058-67."
            }, 
            {
                "PMID": "17611565", 
                "citation": "Tavernier E, Boiron JM, Huguet F, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lheritier V, Vernant JP, Dombret H, Thomas X; GET-LALA Group; Swiss Group for Clinical Cancer Research SAKK; Australasian Leukaemia and Lymphoma Group. Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia. 2007 Sep;21(9):1907-14. Epub 2007 Jul 5."
            }, 
            {
                "PMID": "17039234", 
                "citation": "Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela JM, Dombret H, Dastugue N, Huguet F, Bastard C, Stamatoulas A, Giollant M, Tournilhac O, Macintyre E, Buzyn A, Bories D, Kuentz M, Dreyfus F, Delannoy A, Raynaud S, Gratecos N, Bordessoule D, de Botton S, Preudhomme C, Reman O, Troussard X, Pigneux A, Bilhou C, Vernant JP, Boucheix C, Gabert J; GET-LALA Group the Swiss Group for Clinical Cancer Research (SAKK). Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia. 2006 Dec;20(12):2155-61. Epub 2006 Oct 12."
            }, 
            {
                "PMID": "15637138", 
                "citation": "Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM, Reman O, Cayuela JM, Lheritier V, Vernant JP, Fiere D, Macintyre E, Dombret H. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood. 2005 Apr 15;105(8):3072-8. Epub 2005 Jan 6."
            }, 
            {
                "PMID": "15353542", 
                "citation": "Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Vernant JP, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lheritier V, Fiere D. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004 Oct 15;22(20):4075-86. Epub 2004 Sep 7."
            }, 
            {
                "citation": "Asnafi V, Buzyn A, Thomas X, et al.: Impact of immunophenotype and genotype on outcome in LALA94 T-ALLs: toward risk adapted stratification of adult T-ALL. [Abstract] Blood 102 (11): A-67, 2003."
            }, 
            {
                "PMID": "12239143", 
                "citation": "Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A, Bilhou-Nabera C, Cayuela JM, Fenaux P, Bourhis JH, Fegueux N, Charrin C, Boucheix C, Lheritier V, Esperou H, MacIntyre E, Vernant JP, Fiere D; Groupe d'Etude et de Traitement de la Leucemie Aigue Lymphoblastique de l'Adulte (GET-LALA Group). Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. Blood. 2002 Oct 1;100(7):2357-66."
            }
        ], 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "collaborator": {
                "agency": "Acute Leukemia French Association", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1995", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }, 
    "geocoordinates": {
        "A. Perrino Hospital": "40.636 17.939", 
        "A.Z. St. Jan": "51.211 3.225", 
        "Algemeen Ziekenhuis Middelheim": "51.219 4.403", 
        "C.H.U. Saint-Pierre": "50.85 4.352", 
        "CHU Sart-Tilman": "50.633 5.58", 
        "Centre Hospitalier Peltzer-La Tourelle": "50.591 5.866", 
        "Centre Medico-Chirurgical Foch": "48.87 2.219", 
        "Groot Ziekengasthuis 's-Hertogenbosch": "51.698 5.317", 
        "Hopital Edouard Herriot": "45.764 4.836", 
        "Hopital Necker": "48.857 2.352", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Hospital Escolar San Joao": "41.15 -8.61", 
        "Hotel Dieu de Paris": "48.857 2.352", 
        "Ibn-i Sina Hospital": "39.921 32.854", 
        "Institute of Hematology & Transfusiology, University Hospital": "48.146 17.107", 
        "Istituto di Ematologia Universita - University di Sassari": "40.727 8.558", 
        "Kreiskrankenhaus Meissen": "51.162 13.498", 
        "Leiden University Medical Center": "52.16 4.494", 
        "Maxima Medisch Centrum - locatie Eindhoven": "51.442 5.47", 
        "Medical School/University of Zagreb": "45.815 15.979", 
        "Onze Lieve Vrouwe Gasthuis": "52.37 4.895", 
        "Ospedal SS Annunziata": "40.469 17.24", 
        "Ospedale Casa Sollievo della Sofferenza": "41.707 15.725", 
        "Ospedale Civile Alessandria": "44.913 8.617", 
        "Ospedale Civile Avellino": "40.915 14.793", 
        "Ospedale Di Montefiascone": "42.538 12.036", 
        "Ospedale Ferrarotto": "37.502 15.088", 
        "Ospedale Gen. Provinciale Santa Maria Goretti": "41.468 12.904", 
        "Ospedale Maggiore Lodi": "45.313 9.498", 
        "Ospedale Molinette": "45.071 7.684", 
        "Ospedale Regionale A. Pugliese": "38.911 16.588", 
        "Ospedale S. Antonio Abate": "45.66 8.793", 
        "Ospedale S. Gennaro ASL NA1": "40.84 14.253", 
        "Ospedale San Carlo": "40.637 15.802", 
        "Ospedale Santa Croce": "44.389 7.547", 
        "Ospedali Riuniti Foggia": "41.462 15.545", 
        "Policlinico - Cattedra di Ematologia": "38.116 13.361", 
        "Policlinico Monteluce": "43.111 12.389", 
        "Policlinico di Careggi": "43.769 11.257", 
        "Universita Degli Studi di Bari Policlinico": "41.126 16.872", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Hospital - Olomouc": "49.595 17.252", 
        "University Hospital Rebro": "45.815 15.979", 
        "University Medical Center Nijmegen": "51.843 5.855"
    }
}